Bio-Rad Laboratories, Inc. (BIO) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to Bio Rad's First Quarter twenty twenty six Results Conference Call and Webcast. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. I would now like to turn the conference over to Ruben Argueta, BIORAD's Head of Investor Relations. You may begin. Thank you, Regina. Good afternoon, everyone, and thank you for joining us. My name is Ruben Argueta, BIORAD's new Head of IR. It's a pleasure to join the team and be with you here. Today, we will review the financial results for the first quarter ended 03/31/2026, and provide an update on key business trends for BIORET. With me on the call today are Norman Schwartz, our Chief Executive Officer John DiVincenzo, President and Chief Operating Officer and Roop Lakaragi, Executive Vice President and Chief Financial Officer. Before we begin our review, I would like to remind everyone that we will be making forward looking statements about management's goals, plans and expectations, our future financial performance and other matters. These statements are based on assumptions and expectations of future events that are subject to risks and uncertainties. Our actual results may differ materially from these plans, goals and expectations. You should not place undue reliance on these forward looking statements, and I encourage you to review our filings with the SEC, where we discuss in detail the risk factors in our business. The company does not intend to update any forward looking statements made during the call today. Finally, our remarks today will include references to non GAAP financ...